Criteria Required for Nomination to the FDA International Inspection Cadre
Investigators:
Analysts:
SPECIFIC REQUIREMENTS FOR INVESTIGATORS:
Drug Investigators: Successfully completed Basic Drug Manufacturing Quality Control Course and Industrial Sterilization (or equivalent**).
Device Investigators: Successfully completed Basic Medical Device Training Course and Process Validation or Industrial Sterilization (or equivalent**).
Biologics Investigators: Blood Banks/Plasma Center: Completed Basic Blood Banking and Plasmapheresis Course and Advanced Blood Banking and Plasmapheresis Course (or equivalent**). Biologics Products: Drug Manufacturing and Quality Control and Industrial Sterilization (or equivalent**).
Food Investigators: Successfully completed LACF or Seafood HACCP and Basic Microbiological Training Course.
BIMO Investigators: Successfully completed Clinical and/or Non-Clinical Bioresearch Monitoring Training Course (or equivalent**).
SPECIFIC REQUIREMENTS FOR ANALYSTS:
Must document training/experience to reflect adequate knowledge/skills/abilities in the program area proposed for nomination. A proven track record showing experience on team inspections, or letters of commendation, etc., for performance on team inspections.
SPECIALIZED REQUIREMENTS FOR INVESTIGATORS AND ANALYSTS:
(Not mandatory, except for certain program areas, as described under specific requirements, if the Investigator/Analyst can show alternate experience in lieu of FDA requirement)
Courses in:
**
Equivalent or alternate experience based on inspection experience (e.g., conducted three or more independent inspections in the program area showing competency and understanding of concepts along with additional OJT experience). Level II Device Certification is deemed equivalent.
FMD 13A
Distribution: | Regional Food and Drug Directors and District Directors |
FDA Headquarters Offices | |
Issued by: | ORA/ORO/Division of Field Investigations (HFC-130) |
Authority: | ORA |
Publication Date: | November 2002 |
This page was last updated on: 02/12/2003.